INTRODUCTION
============

One of the fundamental questions in enzyme catalysis is how an enzyme can stabilize a reaction intermediate and transition state during enzymatic reaction to accelerate the enzyme-catalyzed reaction rate over the non-enzymatic one. The low-barrier hydrogen bond (LBHB) has been invoked to explain a large amount of the energy that is required to stabilize the intermediate in many enzyme reactions ([@b13-molce-38-5-409]). An LBHB has been hypothesized to occur when the distance between the two heteroatoms is less than the sum of their van der Waals radii and the p*K*~a~ values of the hydrogen bond partners are similar to each other, so that they exhibit a covalent character that is absent in an ordinary hydrogen bond ([@b7-molce-38-5-409]; [@b10-molce-38-5-409]). The covalent character of LBHB could increase its strength; i.e., its ΔH of formation increase by as much as 10--20 *k*cal/mol ([@b8-molce-38-5-409]; [@b38-molce-38-5-409]). Among the conventional physicochemical parameters used to characterize LBHBs, the unusual chemical shift of proton nuclear magnetic resonance (NMR) near 16 to 20 ppm in the downfield region is regarded as the clearest evidence for the presence of LBHBs in proteins ([@b7-molce-38-5-409]; [@b10-molce-38-5-409]). However, the degree to which LBHB contributes to catalysis is controversial ([@b2-molce-38-5-409]; [@b25-molce-38-5-409]; [@b29-molce-38-5-409]; [@b30-molce-38-5-409]). A theoretical calculation led to a conclusion that LBHB cannot stabilize the transition-state more than can ordinary hydrogen bonds ([@b35-molce-38-5-409]). Experimental evidence in model compounds suggested that LBHBs might not contribute additional energy to the hydrogen bond between a hydrogen bond donor and acceptor that have matched p*K*~a~s ([@b31-molce-38-5-409]).

Δ^5^-3-ketosteroid isomerase (KSI) catalyzes the allylic rearrangement of the 5,6 double bond of Δ^5^-3-ketosteroids to the 4,5 position, and accelerates the reaction by a factor of 10^11^ compared to the nonenzymatic reaction by an intramolecular proton transfer ([Fig. 1](#f1-molce-38-5-409){ref-type="fig"}) ([@b28-molce-38-5-409]). Two bacterial KSIs, one from *Comamonas testosteroni* and one from *Pseudomonas putida* have been studied to understand the enzyme-catalyzed heterolytic C-H bond cleavage that occurs in a wide variety of biological reactions ([@b12-molce-38-5-409]). In the reaction catalyzed by KSI, Tyr14 and Asp99 are thought to have critical functions in stabilizing a dienolate intermediate by forming LBHB or ordinary hydrogen bonds with the oxyanion of the intermediate ([@b5-molce-38-5-409]; [@b19-molce-38-5-409]). The ^1^H NMR spectrum of KSI complexed with equilenin (i.e., an intermediate analogue in the reaction) shows a highly deshielded proton resonance near 17 ppm, which has been regarded as compelling evidence for the involvement of LBHB in the catalysis ([@b6-molce-38-5-409]; [@b40-molce-38-5-409]; [@b41-molce-38-5-409]). NMR spectroscopic studies combined with site-directed mutagenesis have revealed that an LBHB can form between Tyr14 Oη and C3-O of equilenin in the active site of D38N ([@b15-molce-38-5-409]). The strength of the LBHB in *C. testosteroni* KSI has been estimated to be at least 7.1 kcal/mol by comparing the dissociation rates of the intermediate from the Y14F and the D38N mutants ([@b37-molce-38-5-409]) and by measuring the proton exchange rate of the LBHB over the pH range 4.3 to 9.0 ([@b40-molce-38-5-409]; [@b41-molce-38-5-409]). The Y14F mutation reduced *k*~cat~ of *C. testosteroni* KSI by a factor of 5 × 10^4^ ([@b23-molce-38-5-409]) but that of the D99A mutation only a factor of 5 × 10^3^ ([@b36-molce-38-5-409]). In addition, Y14F and D99A mutants of *P. putida* KSI (in this paper we number the residues of *P. putida* KSI according to those of *C. testosteroni* KSI) are only 1/2,000 and 1/98 times as active as the wild-type KSI ([@b18-molce-38-5-409]; [@b20-molce-38-5-409]), respectively; this change suggests that by forming LBHBs, Tyr14 contributes to catalysis more crucially than does Asp99.

In this study, we measured the energetic difference between LBHB and the ordinary hydrogen bond in the active site of *P. putida* KSI. Together with the structural analyses for the hydrogen bonds involved in the catalytic reaction of *P. putida* KSI, our NMR spectroscopic studies revealed that the putative LBHB between Tyr14 Oη and C3-O of equilenin observed for D38N KSI was converted to an ordinary hydrogen bond by the Y30F/Y55F mutations. The conversion of the LBHB to an ordinary hydrogen bond resulted in only marginal effects on both catalytic activity of KSI and its binding affinity for the intermediate analogue. Our results suggest that the contribution of LBHB to catalysis should be only marginal compared with that of an ordinary hydrogen bond in the active site of KSI.

MATERIALS AND METHODS
=====================

Materials
---------

5-androstene-3,17-dione (5-AND), androstenolone, equilenin and estrone were purchased from Steraloids Inc. (USA). ^15^N-Labeled NH~4~Cl was purchased from Cambridge Isotope Laboratories Inc. (USA). A Superose 12 gel filtration column was purchased from Amersham Bioscience (USA). All chemicals for the buffer solution were purchased from Sigma (USA). All enzymes for DNA manipulation were purchased from Promega (USA). Oligonucleotides were obtained from Genotech Inc. (Korea).

Site-directed mutagenesis, expression and purification of mutant KSIs
---------------------------------------------------------------------

Site-directed mutagenesis of Y115F, Y115F/D38N, Y30F/Y55F/Y115F, Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N was conducted as described previously ([@b22-molce-38-5-409]). All mutations were confirmed by sequencing the entire gene of the mutant KSI. Mutant KSIs were overexpressed in *Escherichia coli* BL21(DE3) (Novagen) harboring an expression vector plasmid containing the mutant KSI gene, and were purified as described previously ([@b3-molce-38-5-409]; [@b16-molce-38-5-409]). The purity of KSI was confirmed by the presence of only one band in SDS-PAGE.

NMR spectroscopy
----------------

NMR was performed as described previously ([@b17-molce-38-5-409]). The NMR sample was adjusted to contain 15 mg/ml KSI in 40 mM potassium phosphate buffer at pH 7.0 containing 1 mM EDTA and 10% DMSO-d~6~ (dimethyl sulfoxide-d~6~) (v/v). NMR spectra were collected on a spectrometer (Bruker, Avance DRX500) equipped with a triple resonance, pulse field gradient probe with actively-shielded z-axis gradients, and a gradient amplifier unit. A jump-and-return pulse sequence ([@b27-molce-38-5-409]) was used to suppress the water signal. The observed ^1^H chemical shifts were determined relative to that of sodium 2,2-dimethyl-2-silapentane-5-sulfonate as an internal standard. All experiments were conducted at 270 K with 1,000 scans acquired for each spectrum; the relaxation delay was 2 s. The spectral width of 20,000 Hz was used in 16,384 points. Line-broadening of 10 Hz was used when processing the data on a workstation (Silicon Graphics, IndyPC) using a software program XWIN-NMR v. 1.2.

Determination of dissociation constants for steroid inhibitors
--------------------------------------------------------------

The affinity of KSI for equilenin, androstenolone, or estrone was assessed by measuring the extent of quenching of intrinsic tryptophan fluorescence of KSI upon the binding of the respective steroid. The fluorescence intensities of KSI were measured with excitation at 295 nm and emission at 315 nm after adding successively various amounts of the steroid dissolved in DMSO to the solution of KSI. After correcting the data with appropriate dilution factors, dissociation constants were determined by fitting the data to the following equation: $${\lbrack\text{I}\rbrack}_{\text{t}} = \left( {F_{0} - F} \right)\left\{ {K_{\text{D}}/\left( {F - F_{\infty}} \right) + \lbrack\text{E}\rbrack/\left( {F - F_{\infty}} \right)} \right\},$$where \[I\]~t~ is the concentration of total steroid in the solution, *F* is the fluorescence intensity, *F*~0~ is the intensity in the absence of any steroid, *F*~∞~ is the intensity in infinite steroid concentration, \[E\] is the concentration of KSI, and *K*~D~ is the dissociation constant.

Determination of kinetic parameters, *k*~cat~ and *K*~M~
--------------------------------------------------------

Enzymatic reactions were initiated by adding KSI to 3 ml of a solution containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA, 3.3% methanol, and the respective amount of a steroid substrate, 5-AND. The final concentration of methanol in the reaction mixture was 3.3% by volume. All the assays were performed at 298 K. Kinetic parameters such as *k*~cat~ and *K*~M~ were obtained by utilizing Lineweaver-Burk reciprocal plots under the assay conditions in which the substrate concentrations were 23.3, 34.9, 58.2, 81.5, and 116.4 μM.

Crystallization and structure determination of mutant KSIs
----------------------------------------------------------

Crystallization of Y30F/Y55F/Y115F/D38N KSI complexed with equilenin was conducted using a hanging drop vapor diffusion method as described previously ([@b4-molce-38-5-409]; [@b6-molce-38-5-409]). After 20 mg/ml of the mutant KSI was prepared in a buffer containing 40 mM potassium phosphate, pH 7.0, 1 mM EDTA, and 20 mM β-mercaptoethanol, the 70 μl of this solution was mixed with 2 μl of 10 mM equilenin in dimethyl sulfoxide. The optimized crystallization for the mutant KSI was 0.1 M sodium acetate, pH 4.5, 0.6 M ammonium acetate, and 30% PEG 4000. All diffraction data were collected on beamline 5C at Po-hang Accelerator Laboratory (PAL), Korea. The diffraction images were integrated and scaled using the HKL-2000 software package ([@b24-molce-38-5-409]). The structure of Y30F/Y55F/Y115F/D38N complexed with equilenin was determined by the molecular replacement method using as a search model the coordinates of wild-type KSI that had been determined previously ([@b19-molce-38-5-409]). Model building was performed using Coot ([@b9-molce-38-5-409]) and refinement was performed using Phenix.refine ([@b1-molce-38-5-409]). The atomic coordinate of Y30F/Y55F/Y115F/D38N complexed with equilenin was deposited at the Protein Data Bank (PDB code 5AI1).

RESULTS
=======

Effects of tyrosine-to-phenylalanine substitution(s) in *P. putida* KSI on LBHB
-------------------------------------------------------------------------------

The Y30F/Y55F/Y115F/D38N mutant KSI that contains no tyrosine residue other than Tyr14 was prepared to investigate the role of Tyr14 in the formation of LBHB without any interference from the other three tyrosines (Tyr30, Tyr55, Tyr115) in *P. putida* KSI. A highly deshielded proton resonance was not observed in the downfield region of the NMR spectrum of Y30F/Y55F/Y115F/D38N KSI complexed with equilenin ([Fig. 2E](#f2-molce-38-5-409){ref-type="fig"}), although Tyr14 still has a hydrogen bonding capability in the active site of the mutant. To determine why LBHB is absent in the Y30F/Y55F/Y115F/D38N-equilenin complex, the tyrosines at positions 30, 55, and 115 in D38N were replaced individually with a phenylalanine. The ^1^H NMR spectra of the Y30F/D38N, Y55F/D38N, and Y115F/D38N mutants revealed that LBHB between Tyr14 Oη and C3-O of equilenin was not perturbed significantly by the Y30F, Y55F, or Y115F mutation ([Figs. 2A](#f2-molce-38-5-409){ref-type="fig"}, [2B](#f2-molce-38-5-409){ref-type="fig"}, and [2C](#f2-molce-38-5-409){ref-type="fig"}). In contrast to the single substitutions of tyrosine with phenylalanine, the highly deshielded proton resonance was not observed in the ^1^H NMR spectrum of Y30F/Y55F/D38N-equilenin complex ([Fig. 2D](#f2-molce-38-5-409){ref-type="fig"}); this result indicates that the absence of LBHB in Y30F/Y55F/Y115F/D38N can be attributed to the simultaneous replacements of tyrosines with phenylalanines at the positions 30 and 55 in *P. putida* KSI.

Affinity of steroid to KSI
--------------------------

*K*~D~ values of KSI for equilenin and other steroid inhibitors were determined by analyzing the quenching of the intrinsic fluorescence of the enzyme while varying the steroid concentration. The conditions such as the concentration of DMSO in the fluorescence measurements were the same as those in the NMR experiments. When the mutation of Y30F, Y55F or Y115F was imposed in addition to D38N, the *K*~D~ values of the mutant KSIs were only approximately doubled relative to that of D38N ([Table 1](#t1-molce-38-5-409){ref-type="table"}). The *K*~D~ values of the Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N mutants whose ^1^H NMR spectra exhibited no highly deshielded proton resonance in the downfield region around 16 ppm, were increased by factors of 8.1 and 11, respectively ([Table 1](#t1-molce-38-5-409){ref-type="table"}).

The *K*~D~ values of D38N and Y30F/Y55F/Y115F/D38N were also determined for the steroid inhibitors androstenolone and estrone ([Fig. 3](#f3-molce-38-5-409){ref-type="fig"}). When androstenolone or estrone was bound to D38N KSI, a highly deshielded proton resonance at 16.8 or 18.0 ppm respectively, was observed in the downfield of the ^1^H NMR spectrum. In contrast, the highly deshielded proton resonance was not observed in the ^1^H NMR spectrum of Y30F/Y55F/Y115F/D38N complexed with androstenolone or estrone, respectively. Even if the A and B ring structures of androstenolone and estrone are very different from those of equilenin, the additional tyrosine-to-phenylalanine substitutions reduced the binding affinities of D38N KSI for these steroid inhibitors to a similar extent as that for equilenin ([Table 2](#t2-molce-38-5-409){ref-type="table"}).

Kinetic analyses
----------------

The *k*~cat~ and *K*~M~ values of the mutant KSIs for a steroid substrate (5-AND) were compared with those of the wild type ([Table 3](#t3-molce-38-5-409){ref-type="table"}). A previous investigation on the hydrogen bond network ([@b22-molce-38-5-409]) revealed that the *k*~cat~ values of Y30F and Y55F were decreased by factors of 1.2 and 6 respectively relative to that of the wild-type KSI. These *k*~cat~ values are signifycantly higher than that of Y14F which is lower by a factor of 10^3.2^ than that of the wild-type KSI. In addition, the replacement of Tyr115 with a phenylalanine also resulted in decrease in *k*~cat~ by a factor of 1.5. These results indicate that Tyr30, Tyr55 and Tyr115 are not critically essential for catalysis by *P. putida* KSI even if the contribution of Tyr55 to catalysis is somewhat significant. In spite of the absence of LBHB in the ^1^H NMR spectra, Y30F/Y55F and Y30F/Y55F/Y115F mutant KSIs exhibited relatively high catalytic activities with the *k*~cat~ values decreased marginally by factors of 2.0 and 1.7, respectively, compared with the wild type. These *k*~cat~ values were even significantly higher than that of Y55F whose ^1^H NMR spectrum exhibited a highly deshielded proton resonance at 17.9 ppm, which is similar to that of the wild-type enzyme.

Three-dimensional structure of Y30F/Y55F/Y115F/D38N complexed with equilenin
----------------------------------------------------------------------------

The binding mode of equilenin in the active site of Y30F/Y55F/Y115F/D38N was investigated using X-ray crystallography. The crystals of Y30F/Y55F/Y115F/D38N-equilenin complex were found to belong to the C222~1~ space group with unit cell dimensions of a = 35.2 Å, b = 95.8 Å and c = 73.5 Å. The final structure of Y30F/Y55F/Y115F/D38N-equilenin complex was determined at 2.1-Å resolution. The crystallographic statistics for the final structure are shown in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. The crystal structure of the mutant revealed that the benzyl side chains of the substituted phenylalanines were located at the positions similar to those of the corresponding tyrosine residues in D38N but without the hydroxyl groups ([Fig. 4](#f4-molce-38-5-409){ref-type="fig"}). The hydrogen bond geometry between equilenin and catalytic residues in Y30F/Y55F/Y115F/D38N was very similar to that in D38N. The bound steroid was located in the active site of the mutant with the steroid A-ring approaching Tyr14 and Asp99 ([Fig. 4](#f4-molce-38-5-409){ref-type="fig"}; [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Three catalytic residues, Tyr14, Asp38 and Asp99, which are critical for the catalytic activity of KSI, were found to be located at positions similar to those in D38N. Tyr14 Oη was involved in a hydrogen bond with C3-O of equilenin with a distance of 2.80 Å in the active site of Y30F/Y55F/Y115F/D38N complexed with the steroid.

DISCUSSION
==========

Using KSI as a model system, we investigated the nature and origin of stabilization of the reaction intermediate or the transition-state to explain the enormous rate enhancement of the enzyme-catalyzed reaction over the non-enzymatic reaction. Especially, we investigated the proposition that LBHB can provide an additional energetic contribution to enzyme catalysis compared with the ordinary hydrogen bond. In *P. putida* KSI, LBHB was proposed to be formed between Tyr14 Oη and C3-O of equilenin, an intermediate analogue, in the active site of D38N KSI, as revealed by NMR spectroscopic studies combined with site-directed mutagenesis ([@b15-molce-38-5-409]). The absence of a highly deshieled proton resonance at ∼16 ppm in the ^1^H NMR spectrum of Y30F/Y55F/Y115F/D38N KSI complexed with equilenin clearly indicates that the LBHB between Tyr14 Oη and C3-O of the steroid does not exist in the active site of the mutant KSI. In addition, the distance between Tyr14 Oη and C3-O of equilenin was changed. The distance in the Y30F/Y55F/Y115F/D38N KSI was 2.80 Å, whereas that in D38N KSI was 2.57 Å ([Fig. 4](#f4-molce-38-5-409){ref-type="fig"}). Considering that the major features of a LBHB are a distance \< 2.65 Å between a proton donor and a proton acceptor or a 16- to 20-ppm ^1^H NMR chemical shift in the downfield region, or both ([@b10-molce-38-5-409]; [@b11-molce-38-5-409]), the putative LBHB might be replaced by an ordinary hydrogen bond in Y30F/Y55F/Y115F/D38N KSI.

Tyr14 Oη forms a hydrogen bond with Tyr55 Oη that is in turn hydrogen-bonded to Tyr30 Oη in the active site of *P. putida* KSI ([Fig. 1](#f1-molce-38-5-409){ref-type="fig"}). Tyr55 may have an important function in the formation of LBHB between Tyr14 Oη and C3-O of equilenin by providing a hydrogen bond to Tyr14 and consequently affecting the p*K*~a~ of Tyr14 through the hydrogen bond. The crystal structure of Y55F *P. putida* KSI ([@b22-molce-38-5-409]) revealed a new hydrogen bond between Tyr14 Oη and Tyr30 Oη; this bond compensates for the loss of a hydrogen bond that was provided by Tyr55. Simultaneous replacements of Tyr30 and Tyr55 with phenylalanines in *P. putida* KSI can both disrupt the hydrogen bond between Tyr14 and Tyr55 and change the local dielectric constant of the catalytic site of the mutant KSI; both of these changes can influence the p*K*~a~s of the hydrogen bond partners of the LBHB. Our data suggest that the hydrogen bond between Tyr14 and Tyr55 could be essential to enable the formation of LBHB in the active site of KSI.

The ^1^H NMR spectrum and crystal structure of the Y30F/Y55F/Y115F/D38N KSI complexed with equilenin revealed that LBHB between Tyr14 Oη and C3-O of the steroid in D38N was replaced by an ordinary hydrogen bond. The affinities of the Y30F/Y55F/Y115F/D38N KSI for steroid inhibitors (androstenolone, estrone, equilenin), were lower by factors of 9.1--11 than those of the D38N KSI; this change corresponds to a decrease of only 1.3--1.4 *k*cal/mol in binding energy. This decrease in the binding energy could be attributed to the additional contribution of the LBHB to the steroid binding compared with that of the ordinary hydrogen bond in the active site of KSI. In addition, the catalytic activities of the Y30F/Y55F and Y30F/Y55F/Y115F KSIs were only slightly decreased compared with that of the wild-type enzyme in spite of the conversion of LBHB to an ordinary hydrogen bond in these mutant KSIs. Similar observations have also been reported in other enzyme systems ([@b32-molce-38-5-409]; [@b42-molce-38-5-409]). A serine protease, subtilisin BPN' demonstrated a downfield NMR resonance near 18 ppm that was considered to originate from LBHB in the wild-type subtilisin ([@b32-molce-38-5-409]). This characteristic downfield chemical shift is not present in the D32C subtilisin, but this mutation had only moderate effects on the catalytic activity of subtilisin; this observation suggests that an LBHB does not provide exceptionally high stabilization energy compared with an ordinary hydrogen bond ([@b32-molce-38-5-409]). Carboxymethyldethia coenzyme A, an inhibitor of citrate synthase, forms an LBHB with Asp375 of the enzyme, whereas the primary amine analog of the coenzyme A forms an ordinary hydrogen bond ([@b33-molce-38-5-409]). Only the extra energy of 1.8 *k*cal/mol has been attributed to the LBHB in the active site of citrate synthase by comparing the binding affinities between the carboxyl analog and the primary amine analog of the coenzyme A ([@b33-molce-38-5-409]). A putative LBHB between Asp56 and a phosphate was also found in the crystal structures of phosphate binding protein (PBP) complexes determined at resolutions of 0.98 and 1.05 Å. The D56N mutation that converts the LBHB into an ordinary hydrogen bond resulted in no profound effect on the binding affinity of PBP for a phosphate ([@b34-molce-38-5-409]). These results are consistent with the idea that the additional binding energy and contribution to catalysis provided by an LBHB are not significant compared to those by the ordinary hydrogen bond as observed in the KSI mutants, Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N.

The proton transfer by KSI from the C4 proton of 5-AND with p*K*~a~ of 12.7 to the carboxylate oxygen of Asp38 with p*K*~a~ of 4.5 is energetically unfavorable in solution; calculation indicates that it requires 11 kcal/mol of energy ([@b14-molce-38-5-409]). This high energetic barrier to proton abstraction during the reaction of KSI should be overcome by a very strong interaction; this requirement seems to contradict our observation that LBHB provides only moderate stabilization of the intermediate. However, the energetic barrier in the reaction of KSI might be much smaller than 11 kcal/mol, because the p*K*~a~ difference between the carboxylate of Asp38 and the C4-proton of the steroid substrate can be significantly reduced in the active site of KSI by p*K*~a~ perturbation ([@b14-molce-38-5-409]); crystal structure of wild-type *P. putida* KSI complexed with deoxycholate, a competitive inhibitor of KSI, revealed that the isopentanoate moiety on the steroid D ring was involved in hydrogen bonds with the three catalytic residues, Tyr14, Asp38 and Asp99. Analysis of the hydrogen bonding geometry indicated that Asp38, for which estimated p*K*~a~ = 4.5 ([@b39-molce-38-5-409]), might be in the protonated state at pH 6.7 for the formation of the energetically favorable hydrogen bonds between the inhibitor and catalytic residues ([@b14-molce-38-5-409]). Assuming that the stabilization energy of the intermediate can be significantly reduced due to the p*K*~a~ perturbation of a catalytic base (Asp38), explanation of the diffusion controlled reaction rate of KSI may not require an unusually strong interaction provided by LBHB. The nature of hydrogen bonding in the stabilization of the intermediate was investigated previously in the reaction of KSI by analyzing the binding of substituted phenols to the D38N KSI ([@b26-molce-38-5-409]). The negative charge in the D38N KSI-phenol complex was localized almost exclusively on the bound ligand, with very little charge transfer to the hydrogen bonding groups of the enzyme ([@b26-molce-38-5-409]); this localization is characteristic of ordinary hydrogen bonds. These results indicate that the ordinary hydrogen bond rather than an LBHB would be sufficient to account for the stabilization of the dienolate intermediate during the reaction of KSI.

In conclusion, we have shown that the conversion of LBHB to an ordinary hydrogen bond resulted in only marginal decrease of the catalytic activity and the binding affinity for the intermediate analogue in *P. putida* KSI. Our results indicate that LBHB seems to provide only moderate stabilization of the intermediate in the reaction catalyzed by *P. putida* KSI. Consequently, the enormous rate enhancement achieved by KSI is not attributed solely to the presence of LBHB in the active site. Rather, the enhancement may be due to the sum of many different contributions including hydrogen bonds, electrostatic and hydrophobic interactions, and positioning of the substrate on the enzyme.
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![Reaction catalyzed by ketosteroid isomerase. Androstenolone, equilenin, and estrone are analogues of substrate, intermediate, and product of KSI, respectively. The β proton at C-4 is transferred by Asp 38 to the β side of C-6 during the isomerization reaction. Both Tyr14 and Asp99 can stabilize the intermediate by forming a hydrogen bond with the oxyanion of the intermediate. Tyr14 is hydrogen-bonded to Tyr55 that is in turn hydrogen bonded to Tyr30 in the *P. putida* KSI.](molce-38-5-409f1){#f1-molce-38-5-409}

![^1^H NMR spectra of *P. putida* KSIs. (A) Y30F/D38N at pH 8.5, (B) Y55F/D38N at pH 7.0, (C) Y115F/D38N at pH 8.5, (D) Y30F/Y55F/D38N at pH 8.5, (E) Y30F/Y55F/Y115F/D38N at pH 7.0, which are complexed with equilenin, respectively. The concentration of KSI is 10 mg/ml and the concentration of DMSO-d~6~ 10%.](molce-38-5-409f2){#f2-molce-38-5-409}

![Structures of important steroid inhibitors of KSI. All the steroid inhibitors have the hydroxyl group at the C3 position that can form a hydrogen bond with Tyr14 and Asp99. The binding affinities of the steroid inhibitors for D38N were lowered to the similar extent by the additional Y30F/Y55F/Y115F mutations irrespective of the structural differences among the inhibitors.](molce-38-5-409f3){#f3-molce-38-5-409}

![Crystal Structure of Y30F/Y55F/Y115F/D38N complexed with equilenin. All the backbone atoms were utilized to superimpose the structures of D38N (PDB code 1E3N) and Y30F/Y55F/Y115F/D38N, which are complexed with equilenin. The active-site residues of D38N are colored in gray and those of Y30F/Y55F/Y115F/D38N in black. The hydrogen bonds are indicated by dotted lines. The PyMOL program was used to display the structures.](molce-38-5-409f4){#f4-molce-38-5-409}

###### 

Effects of the tyrosine-to-phenylalanine substitutions in *P. putida* KSI on the binding of equilenin and the low-barrier hydrogen bond[^a^](#tfn1-molce-38-5-409){ref-type="table-fn"}

  KSI                    *K*~D~[^b^](#tfn2-molce-38-5-409){ref-type="table-fn"} (μM)   Highly deshielded^1^H resonance (ppm)[^c^](#tfn3-molce-38-5-409){ref-type="table-fn"}
  ---------------------- ------------------------------------------------------------- ---------------------------------------------------------------------------------------
  D38N                   (3.1 ± 0.6) × 10^−2^                                          16.8
  Y30F/D38N              (0.7 ± 0.1) × 10^−2^                                          17.6
  Y55F/D38N              (0.8 ± 0.2) × 10^−2^                                          17.9
  Y115F/D38N             (0.7 ± 0.2) × 10^−2^                                          17.1, 16.2
  Y30F/Y55F/D38N         (2.5 ± 0.7) × 10^−1^                                          Not Detected
  Y30F/Y55F/Y115F/D38N   (3.4 ± 0.7) × 10^−1^                                          Not Detected

The *K*~D~ measurements and NMR experiments were performed in a buffer containing 40 mM potassium phosphate, 1 mM EDTA, and 10% DMSO.

Values are mean ± standard deviation from three independent experiments.

Only the ^1^H NMR resonance ranging from 16 to 20 ppm, which is regarded as the most unambiguous evidence for the presence of LBHBs in proteins, were investigated to identify the presence of LBHB in the mutant KSIs.

###### 

Affinities of D38N and Y30F/Y55F/Y115F/D38N KSI for the steroid inhibitors[^a^](#tfn4-molce-38-5-409){ref-type="table-fn"}

  Enzyme                 Steroid                *K*~D~ (μM)[^b^](#tfn5-molce-38-5-409){ref-type="table-fn"}   Highly deshielded ^1^H resonance (ppm)[^c^](#tfn6-molce-38-5-409){ref-type="table-fn"}
  ---------------------- ---------------------- ------------------------------------------------------------- ----------------------------------------------------------------------------------------
  D38N                   equilenin              (3.1 ± 0.6) × 10^−2^                                          16.8
  androstenolone         (3.0 ± 0.7) × 10^−1^   16.8                                                          
  estrone                (1.1 ± 0.4) × 10^−1^   18.0                                                          
  Y30F/Y55F/Y115F/D38N   equilenin              (3.4 ± 0.7) × 10^−1^                                          Not Detected
  androstenolone         3.2 ± 0.3              Not Detected                                                  
  estrone                1.0 ± 0.2              Not Detected                                                  

Measurements were performed in 10 mM potassium phosphate buffer containing 10% dimethyl sulfoxide.

Values are mean ± standard deviation from three independent experiments.

Only the ^1^H NMR resonances ranging from 16 to 20 ppm were investigated to identify the presence of LBHB in KSI.

###### 

Kinetic parameters of the wild type and its mutant KSIs[^a^](#tfn7-molce-38-5-409){ref-type="table-fn"}

  Enzyme                                                        *k*~cat~ (s^−1^)       *K*~M~ (μM)   *k*~cat~ / *K*~M~ (M^−1^s^−1^)   Relative *k*~cat~
  ------------------------------------------------------------- ---------------------- ------------- -------------------------------- -------------------
  WT [^b^](#tfn8-molce-38-5-409){ref-type="table-fn"}           (21.2 ± 0.8) × 10^3^   49.9 ± 1.3    4.3 × 10^8^                      1
  Y14F [^c^](#tfn9-molce-38-5-409){ref-type="table-fn"}         13.3 ± 0.6             17.1 ± 3.1    7.8 × 10^5^                      10^−3.2^
  Y30F [^d^](#tfn10-molce-38-5-409){ref-type="table-fn"}        (17.8 ± 0.1) × 10^3^   55.2 ± 2.0    3.3 × 10^8^                      0.84
  Y55F [^d^](#tfn10-molce-38-5-409){ref-type="table-fn"}        (35.1 ± 0.6) × 10^2^   23.0 ± 1.0    1.5 × 10^8^                      0.17
  Y115F                                                         (14.5 ± 0.4) × 10^3^   41.7 ± 2.0    3.5 × 10^8^                      0.68
  Y30F/Y55F [^d^](#tfn10-molce-38-5-409){ref-type="table-fn"}   (10.7 ± 0.4) × 10^3^   50.2 ± 5.5    2.1 × 10^8^                      0.50
  Y30F/Y55F/Y115F                                               (12.2 ± 0.2) × 10^3^   77.3 ± 5.6    1.6 × 10^8^                      0.57

The assays were performed in a buffer containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA and 3.3 % methanol.

Data from [@b21-molce-38-5-409].

Data from [@b18-molce-38-5-409].

Data from [@b22-molce-38-5-409].

[^1]: These authors contributed equally to this work.
